Table 3.
Kidney recipients, underlying disease, results culture of preservation fluid.
| Recipient | Age/Gender | Underlying Disease | Culture Result Preservation Fluid | Antimycotic Treatment | Candida-Associated Complication | Survival (Follow-up in Days) |
|---|---|---|---|---|---|---|
| 1 | 71/M | Alport Syndrome | C. albicans | Fluconazole | - | 3605 |
| 2 | 5/F | Congenital kidney dysplasia | C. parapsilosis Staphyloccous epidermidis |
- | - | 3763 |
| 3 | 52/F | Diabetic nephropathy | C. albicans | Fluconazole | - | 1916 |
| 4 | 55/M | Henoch Schönlein purpura (HSP) | C. albicans | - | - | 3390 |
| 5 | 44/M | Polycystic kidney disease | C. albicans C. tropicalis |
- | Bleeding arterial anastomsis | 9 |
| 6 | 46/F | Diabetic nephropathy | C. albicans | - | - | 1208 |
| 7 | 60/F | Chronic glomerolonephritis | C. parapsilosis | - | - | 1156 |
| 8 | 62/M | Diabetic nephropathy | C. albicans Propionibacterium acnes |
Caspofungin Fluconazole | Aneurysm anastomosis Candida sepsis |
225 |
| 9 | 49/M | Chronic glomerolonephritis | C. albicans | - | - | 853 |
| 10 | 54/F | Shrink kidney disease | C. albicans | Fluconazole | - | 618 |
| 11 | 22/M | Cystinosis (lysosomal storage disease) | C. albicans Stenotrophomonas maltophilia Staphyloccous epidermidis |
Fluconazole | - | 565 |